PRP:CA:TSX-Purpose Conservative Income Fund Series ETF (CAD)

ETF | Global Neutral Balanced |

Last Closing

CAD 19.95

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Global Neutral Balanced

Symbol Name Price(Change) Market Cap
VBAL:CA Vanguard Balanced Portfolio

-0.27 (-0.81%)

CAD 3.09B
XBAL:CA iShares Core Balanced ETF Port..

-0.13 (-0.44%)

CAD 1.58B
VCNS:CA Vanguard Conservative ETF Port..

-0.17 (-0.58%)

CAD 0.51B
ZBAL:CA BMO Balanced ETF

-0.08 (-0.20%)

CAD 0.25B
ZMI:CA BMO Monthly Income

+0.01 (+0.06%)

CAD 0.13B
PINC:CA Purpose Multi-Asset Income Fun..

+0.05 (+0.27%)

CAD 0.07B
HCON:CA Global X Conservative Asset Al..

-0.03 (-0.22%)

CAD 0.05B
PIN:CA Purpose Monthly Income Fund Se..

N/A

CAD 5.89M

ETFs Containing PRP:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Global Neutral Balanced) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.89% 22% F 36% F
Dividend Return -13.24% 25% F 1% F
Total Return -7.35% 22% F 11% F
Trailing 12 Months  
Capital Gain 5.89% 11% F 22% F
Dividend Return -13.24% 25% F 1% F
Total Return -7.35% 22% F 11% F
Trailing 5 Years  
Capital Gain -2.83% 11% F 32% F
Dividend Return -7.36% 25% F 1% F
Total Return -10.18% 22% F 17% F
Average Annual (5 Year Horizon)  
Capital Gain -1.02% N/A N/A 30% F
Dividend Return 0.18% N/A N/A 27% F
Total Return 1.20% N/A N/A 40% F
Risk Return Profile  
Volatility (Standard Deviation) 5.21% N/A N/A 93% A
Risk Adjusted Return 3.43% N/A N/A 28% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike